Article
Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
Thrombosis and haemostasis - 1 Dec 2014
Park Y, Jeong Y-H, Tantry U S, Ahn J H, Kim K H, Koh J-S, Park J-R, Hwang S-J, Kwak C H, Hwang J-Y, Gurbel P A
Abstract excerpt
Adjunctive use of phosphodiesterase (PDE) inhibitor can enhance antiplatelet and vasoprotective properties in patients with cardiovascular disease. The aim of this study was to evaluate the impact of PDE5 inhibitor dipyridamole on platelet function in stented patients with high platelet reactivity (HPR) during dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Patients with HPR after 600-mg...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.